Last reviewed · How we verify
Atezolizumab - 28 Day Cycle (atezolizumab-28-day-cycle)
At a glance
| Generic name | atezolizumab-28-day-cycle |
|---|---|
| Sponsor | Pfizer Inc. |
| Modality | Monoclonal antibody |
| Phase | Phase 1 |
Approved indications
Common side effects
- DIARRHOEA
- FATIGUE
- ALOPECIA
- NAUSEA
- ANAEMIA
- Diarrhoea
- DECREASED APPETITE
- Fatigue
- ASTHENIA
- CONSTIPATION
- VOMITING
- COUGH
Key clinical trials
- A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |